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Abstract
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Base excision repair (BER) proteins act upon a significantly broad spectrum of DNA lesions that
result from endogenous and exogenous sources. Multiple sub-pathways of BER (short-path or longpatch) and newly designated DNA repair pathways (e.g., SSBR and NIR) that utilize BER proteins
complicate any comprehensive understanding of BER and its role in genome maintenance,
chemotherapeutic response, neurodegeneration, cancer or aging. Herein, we propose a unified model
of BER, comprised of three functional processes: Lesion Recognition/Strand Scission, Gap Tailoring
and DNA Synthesis/Ligation, each represented by one or more multiprotein complexes and
coordinated via the XRCC1/DNA Ligase III and PARP1 scaffold proteins. BER therefore may be
represented by a series of repair complexes that assemble at the site of the DNA lesion and mediates
repair in a coordinated fashion involving protein-protein interactions that dictate subsequent steps
or sub-pathway choice. Complex formation is influenced by post-translational protein modifications
that arise from the cellular state or the DNA damage response, providing an increase in specificity
and efficiency to the BER pathway. In this review, we have summarized the reported BER proteinprotein interactions and protein post-translational modifications and discuss the impact on DNA
repair capacity and complex formation.

1. Introduction of a unifying BER model
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We propose a unifying model for base excision repair (BER) that describes the processing of
a multitude of DNA lesions conducted by BER proteins. This model includes repair of classical
oxidation and alkylation base modifications and encompasses the repair of single-strand breaks
(processed through a single-strand break sub-pathway), oxidative lesions processed via
alternate sub-pathways such as NIR and repair initiated by the NEIL-family of bi-functional
DNA glycosylases. As will be described, BER functions via a series of transient repair
complexes that assemble at the site of the DNA lesion [1]. As the lesion is processed, additional
proteins are recruited and exchanged to advance the repair process [2]. BER protein complex
formation is further influenced by post-translational protein modifications that provide an
increase in specificity and efficiency to the BER pathway.
BER is the predominant DNA damage repair pathway for the processing of small base lesions,
derived from oxidation and alkylation damage. An estimated rate of 104 damaging events/
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mammalian cell/day underscores the importance of the BER pathway [3-5]. BER is normally
defined as DNA repair initiated by a lesion-specific DNA glycosylase (mono- or bi-functional)
and completed by either of two sub-pathways: short-patch BER; a mechanism whereby only
1 nucleotide is replaced or long-patch BER; a mechanism whereby 2-13 nucleotides are
replaced. The majority of repair is currently thought to occur via the short-patch pathway
initiated by either a mono-functional or bi-functional glycosylase. The paradigm for the shortpatch BER pathway initiated by a mono-functional glycosylase involves base lesion removal
and then AP site hydrolysis by AP endonuclease (APE1) [6], catalyzing the incision of the
damaged strand, leaving a 3’OH and a 5’deoxyribose-phosphate moiety (5’dRP) at the margins.
DNA polymerase ß (pol ß) hydrolyzes the 5’dRP moiety and fills the single nucleotide gap,
preparing the strand for ligation by either DNA Ligase I (LigI) or a complex of DNA Ligase
IIIα (LigIIIα) and XRCC1 (Fig. 1).
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However, oxidative base lesions are primarily removed by bi-functional DNA glycosylases
that also encode an additional 3’AP lyase activity. Upon recognition of a base lesion by a bifunctional DNA glycosylase, the lesion (e.g., 8-oxodG) is excised from the DNA strand in a
mechanism similar to mono-functional DNA glycosylases as depicted above. However, the
DNA backbone can then be incised 3’ to the damage site, leaving a 3’ α,ß-unsaturated aldehyde
(after ß-elimination) and a 5’phosphate at the termini. A 3’ phosphodiesterase activity, supplied
by APE1 [7], cleaves this terminus in preparation for polymerase extension by pol ß and ligation
by LigI or XRCC1/LigIIIα.
Long-patch BER is initiated in a fashion similar to short-patch BER to produce a nicked DNA
intermediate. Repair completion requires a 3’OH moiety for proper nucleotidyl transfer and
chain elongation. In cases where the 5’lesion is refractory to pol ß lyase activity [8], polymerase
δ, ε or ß, coupled with proliferating cell nuclear antigen (PCNA) and a variety of other proteins
including the structure specific flap endonuclease (Fen1), poly(ADP-ribose)polymerase 1
(PARP1) and LigI synthesizes DNA to fill the gap, resulting in a displaced DNA flap of 2-13
bases in length [8-10]. DNA synthesis and strand displacement by pol ß is stimulated by the
combined presence of Fen1 and PARP1 [11,12]. The Werner Syndrome Protein helicase
(WRN) is also observed to stimulate strand displacement activities of pol ß. Fen1 then catalyzes
the removal of the ensuing DNA flap, leaving a nick that has been transferred 2-13 nucleotides
downstream of the original damage site. Finally, the intact DNA strand is restored by LigI (Fig.
1).
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Although this longstanding BER paradigm has been useful in delineating the protein players
and DNA intermediates of the pathway, increasingly it has become clear that the pathway
handles a broader spectrum of lesions than this paradigm can accurately depict. For example,
the single-strand break repair (SSBR) pathway utilizes many of the same proteins as BER,
namely APE1, pol ß and LigIIIα, along with the scaffold proteins PARP1 and XRCC1 [13].
The principal difference between SSBR and BER is the pathway initiation step (Table I). In
each case repair may occur at the single nucleotide level (i.e., short-patch repair) or as a longer
patch of repair. BER as outlined above is initiated via DNA glycosylase activity that results in
the removal of a damaged base. SSBR, on the other hand, is defined specifically for the repair
of single-strand breaks in DNA arising from irradiation, incomplete topoisomerase action or
ROS byproducts of metabolism [14]. PARP1 recognizes the single-strand break, signaling
recruitment of repair proteins to the damaged site [15]. One of the first proteins recruited is
XRCC1, a protein closely associated with BER pathway coordination. PARP1 interacts with
XRCC1 to form the protein scaffold upon which the repair complex is built [16]. Furthermore,
PARP1 has been linked more directly to BER as it interacts both physically and functionally
with pol ß [12,17] and LigIIIα [18], placing it as a member of the short-patch BER pathway
(Table II). In addition, PARP1 coordinates with long-patch BER proteins to facilitate the repair
of longer stretches of DNA [12,19].
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Over the past several years, two additional sub-pathways of BER or alternate repair
mechanisms have been described that utilize unique combinations of BER proteins to repair
base damage. For example, APE1 has been found to initiate DNA glycosylase-independent
repair of oxidized cytosines [20-22]. This alternate repair pathway has been defined as
Nucleotide Incision Repair (NIR), yet can also be considered a minor sub-pathway of BER
with a unique APE1-mediated repair initiation event. More recently, Mitra and colleagues have
defined an APE1-independent BER sub-pathway for repair of oxidized bases initiated by the
DNA glycosylase/AP lyases NEIL1 and NEIL2 [23,24]. Although each of the BER subpathways described above are unique, each pathway is similar in several general biochemical
steps, as depicted in Table I and Fig. 2. This unified BER model acknowledges the mechanistic
similarities among these varied BER sub-pathways yet broadens the pathway entry points to
reflect both the variety of DNA damage able to enter the pathway as well as the plethora of
proteins necessary to process the resulting repair intermediates (Table I). In the proposed model
(Fig. 2) the five canonical BER steps have been reorganized into three distinct phases: Lesion
Recognition/Strand Scission; DNA Gap Tailoring; and DNA Synthesis/Ligation, each
coordinated via the XRCC1/DNA Ligase IIIα and PARP1 scaffold protein complexes and
associated protein-protein interactions (Table II and Fig. 2).

2. Initiation of BER by lesion recognition / strand scission
NIH-PA Author Manuscript

The common denominator in all of these BER sub-pathways is a single-strand break. We
propose to combine all of these sub-pathways into one unifying pathway by broadening the
entry points and focusing on the protein complexes formed as a function of the chemistry of
the resulting repair intermediate. Thus, we propose that this unified BER pathway encompasses
numerous entry points contingent on the type of damage encountered. Entry points include bifunctional glycosylase activity and 3’AP lyase activity with ß-elimination; mono-functional
glycosylase activity and APE1 endonuclease incision; spontaneous base loss followed by APE1
endonuclease incision; direct APE1 endonuclease activity on oxidative damage in a
glycosylase independent manner; NEIL-associated glycosylase activity followed by 3’ AP
lyase activity via ß,δ-elimination; mutagen induced oxidative (e.g. irradiation) damage
generating single-strand DNA breaks with a variety of possible ends; and finally incomplete
topoisomerase function that freezes the covalently-bound protein onto the DNA. Each of these
entry points is represented in Table I which delineates the specific DNA ends and in Fig. 2
under lesion recognition / strand scission, from left to right respectively.
2.1 Mono-functional and Bi-functional DNA glycosylases and AP-site repair
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As mediators of the initial step of BER, glycosylases are critical to the recognition and removal
of DNA base lesions. Their mechanism of action has been extensively studied on a number of
different levels. Kinetic data, with purified protein, suggests that glycosylases may be inhibited
by their own AP site products (for review, see [25]). Evaluation of protein partnerships, such
as with APE1, demonstrate a stimulation of overall catalytic efficiency through glycosylase
displacement resulting in an alleviation of product inhibition. Importantly, regulation of
glycosylase activity via protein-protein interactions has been shown to facilitate improved
lesion recognition and to ensure that initiated repair may be completed via the formation of
lesion-specific repair complexes. For example, thymine DNA glycosylase (TDG) is a monofunctional DNA glycosylase that recognizes G:T and G:U mismatches, among other types of
damage. TDG interacts physically with APE1 [26], the subsequent enzyme in the BER
pathway. This interaction enhances the ability of TDG to excise damaged bases. Together TDG
and APE1 produce the 3’hydroxyl (3’OH) and 5’deoxyribose phosphate (5’dRP). TDG activity
may also be enhanced through other protein partnerships. For example, functional interactions
have been detected between TDG and xeroderma pigmentosum group C protein (XPCHR23B), where XPC-HR23B was shown to promote dissociation from AP sites, stimulating

DNA Repair (Amst). Author manuscript; available in PMC 2008 June 1.

Almeida and Sobol

Page 4

NIH-PA Author Manuscript

TDG turn-over (Table II) [27]. N-methylpurine DNA glycosylase (MPG) is the general DNA
glycosylase for most types of DNA alkylation damage. Recently MPG was reported to interact
physically with the human scaffolding protein XRCC1, stimulating activity of MPG and
supporting the hypothesis that single-strand alkylation damage is processed via XRCC1
scaffold protein coordination [28].
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Bi-functional glycosylases add an additional level of complexity due to their 3’ AP lyase
activity, yielding a replication-blocking 3’ ß-eliminated unsaturated aldehyde and a
5’phosphate at the margins of the repair gap. Until recently, glycosylase action and catalysis
to yield the ß-elimination product were thought to occur concomitantly. However, studies with
bi-functional glycosylases such as human endonuclease III (NTH1) and mammalian 8oxoguanine-DNA N-glycosylase homolog (OGG1), suggest a dissociation of the two activities.
Studies of hNTH1 (activity and binding affinity to thymine glycol (Tg) containing DNA)
revealed that the 3’AP lyase activity of the enzyme is dependent on the binding affinity of the
enzyme to its product AP site [29]. Indeed, APE1-assisted dissociation of NTH1 was so
effective in abrogating the 3’lyase activity that upon activation of APE1, only 5’dRP (APE1
product) was detectable, not the products of ß-elimination. Therefore, under physiological
conditions (i.e. abundant APE1), NTH1 may act as a mono-functional glycosylase on Tg:A
damaged DNA, shuttling damage towards cleavage by APE1, which has a greater capacity to
cleave 5’ to the AP site than 3’ to the ß-elimination product [30]. Similarly, OGG1and MYH
showed an enhancement of glycosylase activity and suppression of the glycosylase 3’ lyase
function upon addition of APE1, suggesting that circumventing the 3’lyase activity is
commonly observed for bi-functional glycosylases in vivo [31-33]. This reduction of the
3’lyase activity of bi-functional glycosylases is further supported by the interaction of OGG1
with XRCC1 [34]. OGG1 interacts physically and functionally with XRCC1 to stimulate base
hydrolysis without inhibiting the subsequent APE1 strand incision step, resulting in an overall
increase in processing of toxic intermediates through the pathway and highlighting the
orchestrating abilities of XRCC1 [34]. Nevertheless, should the 3’unsaturated aldehyde present
as a repair blocking lesion, APE1 3’phosphodiesterase activity has the ability to remove it to
restore active repair [30].
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AP sites are detrimental cellular DNA lesions that give rise to an increase in genetic mutations
and other genetic rearrangements [35]. AP sites are generated through spontaneous base loss
in addition to glycosylase action [5]. The sheer quantity of this lesion suggests that a tightly
controlled system is necessary for accurate repair. APE1 recognizes these AP sites and incises
the DNA 5’ to the lesion, leaving the 3’OH and 5’phosphate residues, as described above. Mice
with a targeted homozygous null mutation in the APE1 (Ref-1) gene die during early embryonic
development [36]. Detailed analysis of APE1 null embryos (pre-implantation APE1 null
embryos) following ionizing radiation indicate a role for APE1 in the repair of ionizing-induced
DNA damage [37]. No other APE1-deficient mammalian cellular models are available, making
in vivo studies in mammalian systems challenging. The recent demonstration that siRNA may
be used to down-regulate APE1 does however show promise for future studies to define the
role of APE1 in mammalian cells in vivo [38]. However, complete depletion may be impossible
as it is shown to be essential for cellular survival [39]. Although AP-site specific
5’endonucleolytic activity is the major function of APE1, there are a number of minor functions
associated with APE1 as well, including 3’phosphodiesterase, 3’phosphoglycolase,
3’phosphatase and 3’-5’exonuclease capabilities. Many of these alternate functions participate
in the gap-tailoring of 3’ blocked termini within a repair patch. Physical and functional
partnerships with APE1 include a number of DNA repair proteins such as LigI, Fen1, PCNA,
pol ß and most importantly, XRCC1 (see Table II). APE1 physically interacts with XRCC1,
enhancing endonucleolytic incision rates and coordinating AP site repair initiation with
subsequent gap-tailoring enzymes [40].
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2.2 Direct APE1-mediated nucleotide incision as an initiator of BER
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APE1 directly incises the damaged DNA duplex upstream of an oxidatively damaged base,
leaving a 3’OH and a 5’phosphate-containing damaged nucleotide at the margins. In other
words, for specific types of oxidative damage, APE1 has the ability to cleave the damaged
DNA strand in a glycosylase-independent manner. This novel function of APE1 was the driving
force behind the development of the alternative BER pathway called nucleotide incision repair
(NIR) [41]. Although kinetic data suggest that 5-hydroxy-2’-deoxycytidine (5OH-C) residues
are inefficiently repaired by DNA glycosylases NTH1 and NEIL1 coupled with either APE1
3’phosphodiesterase or 3’phosphotase activity, Daviet et. al. determined that NIR activity was
predominant towards 5OH-C in cell-free extracts, presumably due to the exceptionally high
concentration of APE1 in the cellular milieu [20]. The resulting 5’modified nucleotide would
be a substrate for Fen1, the flap endonuclease, associated with long-patch BER. APE1 partners
physically with Fen1, resulting in a marginally increased activity of Fen1 5’ flap removal
[42]. Moreover, APE1 stimulated the endonucleolytic activity of Fen1 on DNA flaps of
increasing length, suggesting that the APE1 influence on Fen1 catalytic capacity increases as
more strand displacement occurs [43], and that repair of these lesions is more likely to be
completed through long-patch BER. APE1 also stimulated the resealing capability of LigI
[43] and has been demonstrated to interact physically with PCNA [42]. All of these proteins
are essential to long-patch repair, implying a coordination of the long-patch pathway by APE1
and that 5OH-C damage may proceed through a long-patch BER repair mechanism as depicted
in Fig. 2.
2.3 NEIL2 DNA glycosylase initiated repair
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In the past several years, a distinct subdivision of bi-functional glycosylases has been reported
[44,45]. The human bi-functional glycosylases NEIL1 and NEIL2 process oxidized base
damage in a fashion similar to OGG1 and NTH1, however NEIL1/2 further processes the 3’unsaturated aldehyde through a ß,δ-elimination mechanism to yield a 3’phosphate and
5’phosphate at the margins (Table I) [46]. While APE1 can efficiently process the ß-elimination
product of OGG1 and NTH1, its DNA 3’-phosphatase activity needed for the processing of
the ß,δ-elimination product produced by NEIL1/2 is extremely weak [24]. Therefore NEILmediated repair is independent of APE1 function [24]. Instead, NEIL-mediated repair is
dependent on polynucleotide kinase phosphatase (PNKP) for removal of the 3’ phosphate
[24]. PNKP is a 3’DNA phosphatase and 5’DNA kinase that is traditionally associated with
the SSBR pathway [47]. Finally, both NEIL1 and NEIL2 interact directly with pol ß, Lig
IIIα and XRCC1 and indirectly with PNKP through formation of a larger complex with these
same BER proteins [23]. NEIL-mediated repair clearly falls within the expanded BER pathway
as represented in Fig. 2. NEIL glycosylases hydrolyze the oxidized lesion, leaving a
3’phosphate that directs complex formation of NEIL, pol ß, XRCC1, LigIIIα and PNKP for
the subsequent gap-tailoring step.
2.4 Radiation-induced DNA damage
Single Strand Break Repair (SSBR) describes the repair of single-strand breaks generated by
endogenous oxidative metabolism such as reactive oxygen species (ROS) and environmental
agents such as ionizing radiation in the form of X-rays or gamma-rays. Key steps within the
pathway include PARP1 recognition of and adherence to single-strand breaks. The
PARP1:DNA complex then recruits the scaffold protein XRCC1. The remainder of the
pathway mimics BER both in proteins involved and sub-pathway options available, i.e., shortpatch and long-patch. The hallmark agent for entry into the SSBR pathway is ionizing radiation,
inducing genomic DNA mutations and chromosomal aberrations. Persistent genomic
instability is thought to be a critical step toward the transformation of cells to a cancerous state
[48]. Ionizing radiation generates a bolus of oxygen radical in the water surrounding the DNA
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molecule, resulting in a clustering effect of the damage [49]. Interestingly, these radiation
induced breaks are reported to exist primarily as 5’-phosphate and equal amounts of either 3’phosphate or 3’-phosphoglycolates at the margins of the gap [50-52]. Therefore subsequent
gap-tailoring would require enzymatic activity by either PNKP or APE1.
2.5 Strand-breaks generated by Topoisomerase poisons
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A new entry point into BER is emerging. In this case, a trapped DNA:topoisomerase 1 (Top1)
complex comprises the lesion. Top1 is essential for the relaxation of DNA supercoiling ahead
of the replication machinery [53,54]. If Top1 is inhibited either chemically (for example
through the action of the chemotherapeutic drug camptothecin) or as a result of clustered ROS
damage, the protein remains bound to the DNA creating a toxic single-strand break in actively
replicating cells [55]. Tyrosyl DNA phosphodiesterase (Tdp1) catalyzes the hydrolysis of Top1
from the 3’ terminus of DNA, resulting in a gap with a 3’phosphate and a 5’hydroxyl group at
the margins [56], although there are alternative mechanisms of repair for this lesion involving
Mre11 or Mus81 [57]. After lesion removal by Tdp1, PNKP can then transfer the phosphate
group from the 3’ to the 5’ terminus, thus preparing the DNA ends for repair [58]. If any gapfilling activity is required, pol ß is considered a likely candidate [54,59-62]. Interestingly, both
PNKP and pol ß are known to interact with XRCC1 and it has recently been reported that Tdp1,
critical for the repair of these Top1-mediated lesions, co-immunoprecipitated with XRCC1
[61]. Further, XRCC1 complementation enhanced Tdp1 activity in EM9 cell lines (deficient
in XRCC1 activity) [61]. The PNKP-mediated transfer of a phosphate group was also
stimulated by XRCC1 association [63].
Each of the seven entry points described above depicts a unique type of DNA damage that
results in either the enzymatic or environmentally-induced hydrolysis of the sugar-phosphate
backbone in DNA. The ensuing ends dictate further processing by gap-tailoring enzymes and
thus determine protein complex formation. Furthermore, XRCC1 orchestrates these protein
partnerships by acting as a scaffold upon which the necessary protein complexes can form, and
in the process often stimulating repair.

3. Lesion-driven complex formation
3.1 Scaffold proteins
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XRCC1 was initially cloned in 1990 and found to affect cellular sensitivity to ionizing radiation
[64]. Soon thereafter, a stable complex of XRCC1 and LigIIIα was discovered [65] and by the
late 1990s XRCC1 was established as a BER scaffold protein [66] in partnership with pol ß
and PARP1 [16]. The list of cellular components that interact with XRCC1 has been expanded
to include nicked DNA [67,68] and AP site containing DNA, both intermediates in the BER
pathway [69]. In the past several years, XRCC1 coordination was further expanded to include
pathway initiation enzymes (e.g.; MPG, OGG1 and NEIL2) as well as APE1, firmly
establishing XRCC1 in the orchestration of the entire BER pathway [23,28,34,40]. Thus,
XRCC1 interacts with most, if not all components of the BER short-patch pathway.
Likewise, XRCC1 impacts repair of single-strand breaks via the ternary complex of XRCC1,
LigIIIα and PARP1 [15,18]. PARP1 is believed to be involved in the sensing of DNA nicks
(BER intermediates) [70], acting in conjunction with XRCC1 as a scaffold for the recruitment
of gap-tailoring enzymes. Furthermore, in vivo real time imaging of irradiated or oxidized cells
showed the necessary coordination or recruitment of pol ß by XRCC1, supporting the unified
pathway model proposed here [71]. PNKP also forms a functional complex with XRCC1, pol
ß, and LigIIIα [63], establishing PNKP as the kinase/phosphatase responsible for DNA gaptailoring in response to ROS and irradiation. Likewise, Tdp1 was immunoprecipitated in a
complex with XRCC1 that exhibited both Tdp1 and PNKP activity, suggesting a functional
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interaction between these three proteins [61]. Therefore, all the gap-tailoring enzymes proposed
herein interact physically with XRCC1, including APE1, pol ß, PNKP and Tdp1 (Table II).
Finally, aprataxin, a protein that confers cellular resistance to methyl methanesulfonate and
DNA ssDNA breaks, forms a similar complex including XRCC1, pol ß, and LigIIIα [72-76].
This places aprataxin as a possible gap-tailoring enzyme and will be discussed in the next
section. The nicked DNA is broadly categorized into two groups: those requiring 5’ processing
such as 5’dRP and those requiring 3’ processing such as 3’PO4 and 3’unsaturated aldehydes.
BER protein complex formation is then dictated by the type of DNA ends present in the repair
gap.
3.2 Gap tailoring
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There are currently four enzymes known to modify DNA ends in the context of BER. Pol ß is
the classical BER protein for removal of the 5’dRP moiety resulting from APE1 cleavage.
Interestingly, both DNA polymerase lambda (pol λ) and DNA polymerase iota (pol ι) encode
a 5’dRP lyase function [77,78]. Each has been shown capable of removing the 5’dRP lesion
subsequent to APE1 strand cleavage [77,78] but a deficiency in pol λ or pol ι does not render
cells alkylation sensitive [79], confirming that pol ß is the predominant activity in mouse
embryonic fibroblasts (MEFs) [79]. However, it was demonstrated that pol λ deficient MEFs
are sensitive to hydrogen peroxide [80], suggesting that the participation of either pol λ or pol
ι in BER may be lesion specific. Complementation studies will be required to determine the
precise role, if any, of these alternate BER polymerases in cell survival following genotoxic
stress.
The reaction products of bi-functional glycosylases, 3’-α,ß unsaturated aldehydes, can be
processed by APE1 [81,82]. There is evidence that the coordinated activities of bi-functional
glycosylases, APE1 and XRCC1 suppress 3’lyase activity of the glycosylase through a product
inhibition mechanism, implying that oxidized base damage is shuttled through BER in a fashion
similar to alkylated base damage [83]. In other words, the 3’phosphoglycolate products of
3’lyase activity may not be generated in significant quantities by BER initiation. However,
these types of lesions may be generated by radiation damage and could be processed by APE1
to generate a clean 3’OH end.
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Alternatively, the processing of strand-breaks induced by oxidative damage, which includes
radiation damage, can be accomplished by PNKP [58]. PNKP converts 3’PO4 groups to the
3’OH groups necessary for DNA synthesis [58]. PNKP has also been implicated in the
processing of DNA ends resulting from NEIL glycosylase activity. As described above, NEIL
glycosylase substrates undergo ß,δ-elimination to yield phosphate groups on both the 3’ and
5’ ends. PNKP efficiently removes this replication block generating a 3’OH moiety [46].
Furthermore, a stable complex of NEIL2, PNKP, XRCC1, LigIIIα, and pol ß was isolated as
a ‘repairosome’ from human cells [23].
Strand-breaks generated by Top1 poisons are unique in that they are the result of a covalent
attachment between the DNA and Top1. As such, their removal appears to require a unique
enzyme, Tdp1, which functions within the same XRCC1 scaffold framework as depicted in
Fig 2. Tdp1 removes the 3’tyrosyl moiety leaving the 3’OH necessary for DNA synthesis
[56] and accomplishes this activity through a physical association with XRCC1 that included
a functional dependence on PNKP [61].
The NIR pathway is initiated through APE1 recognition of oxidized base damage followed by
direct cleavage 5’ to the lesion, resulting in a 3’OH and a 5’ modified base. The end would be
refractory to pol ß 5’dRP lyase activity and therefore is unlikely to be repaired through the
XRCC1-mediated short-patch pathway. Instead, removal of this 5’blocking lesion is most
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likely the result of strand displacement and Fen1-mediated hydrolysis and would be shuttled
into the long-patch complex depicted in Fig 2, bottom right complex.
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In 2001, the gene responsible for ataxia-ocular apraxia 1 (AOA1), a neurological disorder
similar to ataxia-telangiectasia, was identified. The protein was named aprataxin (APTX) and
is found to share a distant homology with PNKP [84]. Interestingly, APTX also interacts in
vitro and in vivo with XRCC1 [72-76] and co-immunoprecipitated with PARP1 [73,74].
Moreover, APTX was identified in a complex comprised of XRCC1 and LigIIIα [75], and
ataxia-oculomotor apraxia type 1 patient cells exhibit a marked increase in genome instability
as a function of increasing camptothecin dose, clearly supporting APTX inclusion as a gaptailoring protein in the unified BER model proposed herein. Finally, in vitro investigations
determined that APTX can remove 5’ blocking groups to generate a clean 5’phophate end
[85].
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Werner Syndrome protein (WRN) may also be included as a potential gap tailoring protein
that functions on a 3’lesion. To date there is no evidence that WRN interacts with XRCC1
although it does form a complex with PARP1 [86,87]. WRN is classified as a RecQ family
DNA helicase but has the unique feature of containing a 3’-5’ exonuclease function. WRN was
reported to interact both physically and functionally with pol ß [88]. Recently, the
exonucleolytic capacity of WRN has been assessed as a function of the pol ß interaction.
Specifically, WRN exonuclease activity can act in conjunction with pol ß, a protein with no
intrinsic 3’-5’ proofreading activity [89]. WRN also partners with PARP1, the DNA singlestrand nick sensing protein [87].
Each of these proteins has the ability to tailor the ends of DNA in preparation for subsequent
synthesis and ligation. Furthermore, each of these proteins is reported to interact with XRCC1/
LigIIIα [34,60,61,90], (and in some cases PARP1) supporting the idea that XRCC1/LigIIIα,
together with PARP1, acts as a scaffold to coordinate a broad range of substrates and proteins
through the BER pathway.
3.3 Repair DNA synthesis and DNA ligation

NIH-PA Author Manuscript

In this unified BER model pol ß is shown as the primary polymerase responsible for nucleotidyl
transfer. However, DNA pols δ, ε, γ, ι and λ have all been suggested to participate in BER as
determined by analysis of cell extracts or purified proteins. Pol ß however remains the primary
BER DNA polymerase and the complexes formed are represented in the boxed section of Fig.
2. The complexes are representative of the protein associations possible depending on DNA
end processing requirements and incorporate gap-tailoring protein, scaffold proteins and pol
ß for the nucleotidyl transfer activity. In this unifying model, the DNA Synthesis/Ligation steps
were combined to include substrates requiring ligation without necessarily requiring DNA
synthesis, as depicted in the structure on the right [61]. Specifically, Tdp1-mediated removal
of a 3’tyrosyl residue from the DNA would leave an intact nucleotide complete with a 3’OH
group ready for ligation. Should nucleotide replacement prove necessary, pol ß is the most
likely polymerase candidate.
Apoptosis may be initiated in the event that 3’ blocking lesions prove resilient to removal by
these gap-tailoring proteins. A persistent 5’ blocking lesion however can be removed via the
long-patch BER pathway. Long patch BER has long been established as a complex of proteins
associated to repair larger nucleotide gaps. Fen1, the flap endonuclease responsible for removal
of the 5’blocking lesion, functions in conjunction with PARP1, PCNA, APE1, and pol δ, pol
•, or pol ß. Oxidized bases recognized by the NIR pathway, namely the direct cleavage of DNA
strands containing damage by APE1, may be shuttled directly through the long-patch pathway
as there is no known association between XRCC1 and Fen1.
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Each sub-pathway of BER relies on the formation of protein complexes that assemble at the
site of the DNA lesion and facilitate repair in a coordinated fashion [83]. Table II outlines the
known protein-protein interactions of the proteins involved in BER. This coordination of
protein complex formation that is driven by the lesion or repair intermediate was originally
compared to the passing of a baton, where the repair product of each enzyme in the BER
pathway is “handed” to the sequential enzyme in the pathway [2]. These protein-protein
partnerships can regulate pathway efficacy, dictating subsequent steps or sub-pathway choice.
This mechanism or process of complex formation appears to provide an increase in specificity
and efficiency to the BER pathway, thereby facilitating the maintenance of genome integrity
by preventing the accumulation of highly toxic repair intermediates [83]. Decreased
concentrations of just one protein within this pathway could significantly alter the balance of
complex formation, resulting in reduced repair capacity and an increased exposure to toxic
BER intermediates, such as has been observed in pol ß deficiency in mouse cells [79,91-93],
in animal models [94] and in human cells [62].
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The regulation of BER is further refined through post-translational modifications (PTM).
PTMs can take the form of phosphorylation by protein kinases such as ATM, ATR and DNAPK, acetylation by proteins like p300 and CBP, sumoylation, mono- or poly-ribosylation,
mono- and poly-ubiquitylation or methylation, among others [95]. PTMs can alter the binding
characteristics, turnover rates, sub-cellular localization and/or overall efficacy of the target
protein. Therefore, if modified correctly, the function of the protein is streamlined to meet the
needs of the individual cellular environment. However, if modification is slow or non-existent,
overall pathway efficacy can be greatly reduced, leading to greater longevity of toxic BER
intermediates, impacting mutational load, genomic stability and cellular senescence. In this
section, we describe a few examples of BER protein PTMs to emphasize the significance of
PTMs on BER capacity and have summarized known BER protein PTMs in Table III.
4.1 Modification of proteins that initiate BER via lesion recognition and strand scission
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The most common PTM of BER proteins is phosphorylation. As delineated in Table III, most
of the critical proteins involved in the BER pathway are post-translationally phosphorylated.
This could be the result of cellular signaling cascades that are designed to activate checkpoint
pathways and thus prevent the cell from proceeding with cell division while simultaneously
enhancing DNA repair. Recently, post-translational phosphorylations of OGG1, the
predominant glycosylase for oxidative damage, have been reported [96]. Two independent
kinases were shown to phosphorylate OGG1 in vitro [96]. C-Abl-mediated phosphorylation
of hOGG1 had no effect on activity. However, Cdk4 phosphorylation affected the catalytic
efficiency, resulting in a 2.5 fold increase in 8-oxodG incision activity [96], suggesting that
the modulation of OGG1 activity is dependent on PTM location [96].
Of the remaining DNA glycosylases only MYH and UNG2 are phosphorylated. In each case,
this modification has been observed to increase catalytic activity and hence may regulate BER
initiation [97,98]. On the other hand, TDG, MPG and NEIL2 are modified and regulated by
acetylation (Table III). Whereas acetylation does not appear to regulate TDG, SUMO
modification acts as a regulatory switch by altering its subcellular localization [99-101]. NEIL2
is acetylated by p300 [102]. In this case, acetylation of the Lys49 residue on NEIL2 abrogates
both the DNA excision and the AP lyase activities of the enzyme, effectively inactivating BER
initiation through modification of this glycosylase. Meanwhile acetylation of Lys153 had no
effect on either activity. Although studies identifying PTMs are in their infancy, it appears that
the type and location of PTMs are essential in determining the overall ability to affect DNA
glycosylase-mediated lesion removal. This in turn refines the efficiency of BER pathway
initiation and provides tighter regulation of the BER pathway.
DNA Repair (Amst). Author manuscript; available in PMC 2008 June 1.
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A similar story has unfolded for the APE1 protein, in which all reports agree that APE1 is
phosphorylated by a variety of protein kinases [103-107], but conflict as to the effect of this
modification. Early studies showed that phosphorylation by the serine/threonine casein kinase
I (CKI) and protein kinase C had no effect while modification by CKII abolished repair capacity
completely [107]. Others reported that phosphorylation by CKII did not alter the repair capacity
of APE1 but did stimulate its redox capabilities [103]. Independent of its role in BER, APE1
was purified from HeLa cell extracts as a protein capable of activating the transcription factor
AP-1 via reduction of an oxidized cysteine residue [108]. The multiple roles of APE1 obfuscate
the specific effects that post-translational modifications have on the protein, rendering the
ramifications of specific modifications elusive. Nevertheless, it seems clear that the PTMmediated regulation of APE1 is dependent on the type and site (amino acid residue) of the
modification. Additionally, APE1 is acetylated by the transcriptional co-activator p300;
although this modification has yet to be linked to modulation of the repair capacity of APE1
and appears to influence its redox potential exclusively [109,110].
4.2 BER scaffold proteins and post-translational modifications
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The BER mechanism can be viewed as a multitude of protein complexes unique to the initiating
lesion (Table I), with XRCC1 (in concert with its binding partner LigIIIα) acting as a scaffold
to orchestrate the movement of DNA repair intermediates from repair initiation and strand
scission (DNA glycosylase and APE1) to gap tailoring (APE1 and/or pol ß) and facilitating
repair completion (LigIIIα) through a series of protein interactions [34,111,112]. For example,
an interaction between XRCC1 and PNKP, a protein necessary for the initial processing of
DNA single-strand break termini into ends that are amenable to re-ligation, was shown to be
involved in BER following oxidative stress [58,63]. Interestingly, XRCC1 stimulated both the
kinase and phosphatase activity of PNKP at damaged termini, resulting in an overall
acceleration of single-strand break repair [63], supporting our contention that SSBR may be
considered a sub-pathway of BER. Further, PARP1 interacts exclusively with the BRCT-I
region of XRCC1 and preferentially binds when it is in an active poly(ADP-ribosyl)ated state.
Indeed, XRCC1 has increased affinity for modified PARP1 [113]. Furthermore, PARP1 has
been shown to actively recruit XRCC1 at sites of oxidative stress [114], suggesting that PARP1
senses damage and recruits XRCC1 to act as the scaffold upon which a repair complex can be
constructed.

NIH-PA Author Manuscript

As with most of the BER proteins, XRCC1 and PARP1 present with several different posttranslational modifications that ultimately impact BER function, either directly, by altering
enzymatic activity or indirectly, by altering protein-protein interactions (Table III). XRCC1 is
phosphorylated on at least four amino acid residues (S518, T519, T523 and S371) [75,115,
116]. CK2-mediated phosphorylation of amino acid residues S518, T519 and T523 facilitates
the binding of XRCC1 to aprataxin and increased protein stability of XRCC1 due to the
aprataxin complex formation [75]. Phosphorylation of S371 by DNA-PK appears to be related
to a role for XRCC1 in double-strand break repair [115]. This modification has not yet been
evaluated with regard to its role in BER. XRCC1 was also recently identified as a substrate for
SUMO-modification but has not been characterized further [117]. PARP1 is most abundantly
auto-modified by ADP-ribosylation and further modified by phosphorylation, SUMO and
acetylation (Table III). The reader is referred to an excellent and thorough review of PARPfamily members for more detail [118].
4.3 Post-translational modifications of BER gap tailoring proteins
DNA pol ß interacts with the transcriptional co-activator p300, suggesting that this protein may
regulate BER via a post-translational mechanism [119]. p300 was found to acetylate pol ß at
an amino acid critical for the 5’dRP lyase function: lysine 72. Acetylation at this site blocks
formation of the Schiff-base intermediate and results in abrogation of the 5’dRP lyase activity
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of pol ß but leaves its gap-filling and DNA binding functions unaffected [119]. Whether
acetylated pol ß interacts with other BER proteins in the same manner as unacetylated pol ß
remains to be seen. Nevertheless, p300 may have a novel regulatory role by modulating the
critical pol ß 5’dRP lyase activity that is required for cellular survival following stress [93].
Given the dire consequences of abrogation of the pol ß 5’dRP lyase activity (cellular sensitivity
to alkylating agents) [79,92,93], it seems likely that a de-acetylase, designed to reactivate pol
ß 5’dRP lyase function, is present in vivo but to date has not been identified. It is tempting to
speculate that the reason for 5’dRP lyase abolition is to force repair through long-patch BER,
however, the cellular conditions necessary and the advantage gained from a preference for
long-patch repair remains to be determined.
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As described above, the long-patch sub-pathway utilizes the gap-tailoring properties of Fen1
to remove the displaced DNA flap. Fen1 functionally and physically interacts with pol ß to
promote strand displacement and flap hydrolysis [11,120]. The functionality of Fen1 is further
modified by phosphorylation [121] and acetylation [122,123], each modification providing a
different level of regulation. Whereas phosphorylation prevents Fen1-mediated stimulation of
PCNA, acetylation by p300 appears to reduce the ability of Fen1 to bind to DNA and to function
as a nuclease, with no effect on its PCNA interaction (Table III). WRN also stimulates strand
displacement activities of pol ß [88,89] and is included herein as a gap tailoring protein since
it removes 3’lesions via its 3’⇒5’ exonuclease activity [124] and acts as a participant in
promoting long-patch BER. Similar to Fen1, phosphorylation of WRN decreases its catalytic
activity (Table III). However, p300-mediated acetylation appears to augment the ability of
WRN to translocate to nucleoplasmic foci, suggesting that modification regulates its function
by altering cellular localization [125]. Finally, WRN is also SUMO-modified, via a p53independent interaction with p14 ARF and Ubc9, although it has not yet been established how
or if SUMO-modification may alter the BER-related functions of WRN (See Table III and
references within). None of the other proteins we have listed as gap-tailoring BER enzymes
have been reported to undergo post-translational modification.
4.4 BER DNA synthesis and ligation proteins
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Evidence for a phosphorylated form of pol ß has been reported. In both instances, rat pol ß was
phosphorylated and exhibited higher BER activity than the un-phosphorylated form [126,
127]. The site of phosphorylation is not known but it was determined that the modification is
a serine residue [126]. It is not clear as to the exact nature of the catalytic effect of the phosphatemodification or if phosphorylation impacts protein-protein interactions. Recently, pol ß was
found to form a complex with and is modified by protein arginine methyltransferase 6
(PRMT6), resulting in methylation of R83 and R152. Methylation of these residues stimulated
processive polymerase activity. Single-nucleotide insertions and 5’dRP lyase activity remained
static, however, implying that methylation of pol ß preferentially shuttles repair through longpatch BER [128]. More recently, pol ß was reported to be methylated (in vitro and in vivo) by
PRMT1 but methylation was at amino acid residue 137 [129]. In this case, modification of
arginine 137 did not alter the DNA polymerase activity or 5’ dRP lyase activity but the
interaction with PCNA was diminished.
Both BER DNA Ligases (I and IIIα) undergo post-translational modification in the form of
phosphorylation (Table III). The DNA-PK-mediated phosphorylation of LigI activates the
enzyme and is observed both in vitro and in vivo [130]. The observed in vivo phosphorylation
of LigI corresponds with the generation of double-stranded DNA breaks and may be specific
for the role of LigI in non-homologous end joining. Any role for post-translational
modifications of LigI in BER has not been identified. On the other hand, LigIIIα is
phosphorylated on Ser123 by Cdk2 in a cell-cycle specific fashion and is de-phosphorylated
in an ATM-dependent mechanism linked to the onset of oxidative stress [131]. PCNA is also
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listed as a BER DNA synthesis and ligation related protein and is modified in many ways,
including phosphorylation, acetylation, SUMO and ubiquitin, as listed in Table III. There are
many detailed reviews that characterize the varied post-translational modifications of PCNA
and the impact of these modifications on PCNA-protein interactions [132-134].

5. Conclusion
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We describe a BER model that incorporates the many varied sub-pathways of BER, including
short-patch, long-patch, the repair of single-strand breaks, NIR and repair initiated by the
NEIL-family of DNA glycosylases. As with most DNA repair processes, BER appears to
function via a series of repair complexes that assemble at the site of the DNA lesion [1,135].
BER protein complex formation is further influenced by post-translational protein
modifications that arise from the cellular state or the DNA damage response, providing an
increase in specificity and efficiency to the BER pathway. There are many post-translational
modifications of BER and/or genome stability proteins (Table III), and more PTMs are reported
in the literature regularly. This information, however, is just the beginning of our understanding
of how PTMs influence overall biological processes. Much work needs to be completed before
a clear picture emerges from the impact PTMs have on catalytic efficacy and biological function
with regard to BER. Post-translational modifications play key roles in modulating protein
function [136]. Such post-translational modifications must be identified by direct protein
characterization techniques. In addition, a single protein can play many different roles within
a cell; therefore it is important to characterize its relationship with other proteins to gain a true
understanding of its function(s) at any particular time.
Mouse whole-animal and cellular knockout models have been instrumental in understanding
the cellular and biological role of many BER proteins beyond the biochemical characterization
of substrate identity and specificity. In particular, mouse embryonic fibroblasts (MEFs) have
been a workhorse reagent towards understanding the cellular function of BER proteins with
regard to cell survival, genome integrity, mutagenesis and genotoxicity and for the validation
of and discovery of protein-protein complexes. Clear differences of cellular response between
mouse and human cells, as well as the varied responses from cells of different organ types or
various states of differentiation necessitate continued evaluation of BER proteins isolated from
human cells (tumor cells, stem cells and terminally-differentiated cells). Future studies will
require detailed analysis of how these BER complexes and PTMs impact repair of DNA damage
from endogenous sources to maintain cellular genome integrity. In addition, a valuable next
step is an appreciation of the impact of these complexes and PTM-mediated regulation towards
repair of DNA damage from exogenous sources to evaluate the cellular response to
environmental and chemotherapeutic genotoxins.
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Many of the proteins that participate in BER, as determined by in vitro analysis of purified
proteins and cell extracts or in vivo analysis (whole cell and animal studies) have been identified
[6]. The multiple and varied complexes that form to direct repair of a host of DNA lesions
(Table II) are still being discovered. Further, the interplay of the in situ repair complexes, the
mechanisms of regulation (transcriptional, translational, epigenetic, post-translational or
mediated by micro- or small RNAs) and the impact of repair regulation and cellular function
is an exciting area of current and future studies. We are only beginning to appreciate the
biological impact of mutations that effect BER protein function, protein complex formation,
PTM or all of these. The discovery that MYH variants predispose to somatic mutations and
colorectal tumors underscores the significance of the BER pathway in genome maintenance
[137]. Detailed analyses are forthcoming, for example, to determine if inheritable mutations
in other BER proteins impact human health (e.g., cancer predisposition, neurological function)
and whether these mutations affect BER capacity through disruption of complex formation or
regulation due to defects in post-translational modification.
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Fig 1. Classic BER pathway
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Short-patch pathway (left) depicts sub-pathway initiation by glycosylase activity followed by
strand scission by APE1. Gap tailoring (5’dRP lyase) and nucleotide incorporation are
accomplished by pol ß. The resulting nick is ligated by a complex of XRCC1 and LigIIIα to
complete the pathway. Long-patch pathway (right) depicts a sub-pathway of BER responsible
for repair under conditions of 5’lesions refractory to pol ß cleavage. In this case, BER complex
formation shifts, nucleotide incorporation is conducted either by pol ß or is transferred to polδ or pol-•. The refractory 5’ moiety is removed as part of a flap of DNA by Fen1 and re-ligation
is completed by LigI.
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Fig 2. A unified model of BER

This model depicts protein complexes for repair of oxidation and alkylation base modifications
and encompasses the repair of single-strand breaks, oxidative lesions processed via alternate
sub-pathways such as NIR and repair initiated by the NEIL-family of bi-functional DNA
glycosylases.
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Monofunctional Glycosylase

Topoisomerase I malfunction
Radiation

Alkylation Damage
(e.g. 3Me-adenine)
Spontaneous Base Loss
(e.g. AP Site)
Oxidative Damage
(e.g. 8-oxo-guanine)
Oxidative Damage
(e.g. 5-OH-cytosine)
Oxidative Damage
(e.g. 5-OH-uracil)
Supercoiled DNA

DNA

NEIL1/NEIL2

APE1

Bifunctional Glycosylase

APE1

Enzyme/Event Creating the Break

Substrate Recognized
3’-OH
5’-dRP
3’-OH
5’-dRP
3’-α,ß unsaturated aldehyde
5’- PO4
3’-OH
5’-OH cytosine residue
3’-PO4
5’- PO4
3’-tyrosyl residue
5’-PO4
5’phosphate, 3’phosphate, 3’phosphoglycolate (and others)[138]

DNA Ends Flanking the Gap

Table I

APE1
FEN1
PNKP

Tdp1

PNKP

FEN1

APE1

pol ß

Gap Tailoring Protein
Required
pol ß

SSBR

SSBR

NEIL-directed BER

NIR or LP BER

BER

BER

BER

Current Sub-Pathway
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Interacting Proteins
NDa
PCNA, RPA, Vpr
Vpr
APE1, p300, XPC/HR23B
ND
XRCC1, HR23A, MBD1
XRCC1, CSB
ND
APE1, PCNA, RPA
ND
XPG
pol ß, LigIIIα
pol ß, LigIIIα, PNKP, XRCC1
ND
TDG, MYH, pol ß, LigI, Fen1, PCNA, p53, GzmA
ND
APE1, LigI, Fen1, PCNA, PARP1, PARP2, PNKP, NEIL1, NEIL2, Aprataxin, p53, Trf2, p300, XRCC1, PRMT1,
PRMT6
APE1, pol ß, PCNA
XRCC1, PARP1, PARP2, PNKP, NEIL1, NEIL2, Aprataxin
APE1, pol ß, PCNA, PARP1, p300, WRN, BLM
APE1, pol ß, PARP1, XRCC1, p300, CSB, WRN
MPG, OGG1, APE1, pol ß, LigIIIα, PARP1, PARP2, PNKP, Tdp1, Aprataxin
pol ß, LigIIIα, XRCC1, NEIL1, NEIL2
pol ß, PCNA, XRCC1, p300, CSB, WRN, Ku, LigIIIα
pol ß, LigIIIα, PARP1, XRCC1
pol ß, LigIIIα, PARP1, XRCC1
XRCC1

LigI
LigIIIα
Fen1
PCNA
XRCC1
PNKP
PARP1
PARP2
Aprataxin
Tdp1
a
ND – No interacting proteins identified to date.

BER Proteins
UNG1
UNG2
SMUG
TDG
MBD4
Aag/MPG
OGG1
OGG2
MYH
MTH
NTH1
NEIL1
NEIL2
NEIL3
APE1
APE2
pol ß

Table II

[43,152,158,159]
[15,18,63,66,75,113]
[12,42,43,123,160-164]
[19,42,139,140,146,155,158-161,165-170]
[15,23,28,34,40,60,61,63,66,72-76,113]
[63]
[12,16-19,74,87,113,157,171-173]
[113]
[72-76]
[61]

[28,143,144]
[34,145]
[32,146]
[147,148]
[23]
[23]
[26,38,40,42,43,142,149-151]
[12,17,23,63,66,75,88,113,119,128,129,149,150,152-157]

Citation
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[141]
[26,27,142]
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pol ß
Fen1
WRN

Gap Tailoring

A--[127]
C--[130]
C--[131]
A--[190]

A--[127]; [126]
B--[121]
B--[183-187]

A--[75,115,116]
A--[180]

B--[96]*; C--[96,179]
B--[107]**; C--[103-107,126]

A--[98]

A--[175]; C--[176,177]

Phosphorylation

A--[156]

B--[119]
B--[122]; C--[123]
A--[125]

A--[181]

C--[109,110]

B--[102]

A--[178]

Acetylation
C--[26]

Mouse homolog identified as substrate for modification

##

Stimulated DNA binding and processivity; single nucleotide insertion and 5’dRP lyase activity were not affected

#

Specific for CKII phosphorylation only

Specific for Cdk4 phosphorylation only

**

*

C - No Effect Shown

B - Denotes Decreased Catalytic Efficiency

pol ß
LigI
LigIIIα
PCNA
A - Denotes Increased Catalytic Efficiency

XRCC1
Parp1

BER scaffold

DNA Synthesis and Ligation

Protein
TDG
UNG2
MPG
MYH
NEIL2
OGG1
APE1

Function
Lesion Recognition and Strand
Scission
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Table III

C--[191,192]

C--[188]## and
[189]

C--[117]
C--[117]

Sumoylation
A--[99-101,174]

A--[193]; C--[194]

[182]

B--[176]

Ubiquitylation
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Post translational modifications of BER proteins

A--[128]#

Methylation
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